Updated 02:01:01
Change % 0.00% Stock price unchanged
Change 0.00 Stock price unchanged
Volume 208,483
High 88.04
Low 86.48
Open 86.72
ISIN BE0003818359
Prev close 87.08
# of shares 51.34M
Market cap 4,509.50M EUR

Market closed
Market is closed, opens at 08:00
Price development Latest 1 week 1 month 3 months 6 months 1 year
  87.84 5.2% Stock price increasing 3.5% Stock price increasing 12.2% Stock price increasing -1.6% Stock price decreasing 31.5% Stock price increasing
Powered by TradingView

Company profile

Galapagos is a clinical-stage biotechnology company, involved in the discovery and development of small-molecule medicines. The company's product candidate portfolio includes Filgotinib, a JAK1 inhibitor to treat rheumatoid arthritis, Crohn's disease, and ulcerative colitis; novel therapies in cystic fibrosis (a chronic disease that affects the lungs and digestive system); GLPG1690, a selective autotaxin inhibitor with potential application in idiopathic pulmonary disease; GLPG1972 to treat osteoarthritis; and MOR106 to treat atopic dermatitis.

Copyright Euroinvestor A/S 2018   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
18 July 2018 05:57:09
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20180712.1 - EUROWEB4 - 2018-07-18 06:57:09 - 2018-07-18 05:57:09 - 1000 - Website: OKAY